Immunomodulation of jasmonate functions [Elektronische Ressource] / von Petra ten Hoopen

Rogier

Sujets

• Biologie

Informations

• Publié par: martin-luther-universitat_halle-wittenberg
• Publié le: 01 janvier 2002
• Nombre de lectures: 26
• Langue: English
• Poids de l'ouvrage: 2 Mo

Extrait

Immunomodulation of jasmonate functions














urn:nbn:de:gbv:3-000004374
[ http://nbn-resolving.de/urn/resolver.pl?urn=nbn%3Ade%3Agbv%3A3-000004374 ]


Immunomodulation of jasmonate functions



Dissertation

zur Erlangung des akademischen Grades
Doctor rerum naturalium (Dr. rer. nat.)






vorgelegt der


Mathematisch-Naturwissenschaftlich-Technischen Fakultät
der Martin-Luther-Universität Halle-Wittenberg
Fachbereich Pharmazie





von Petra ten Hoopen
geboren in P řerov, Tschechische Republik



urn:nbn:de:gbv:3-000004374
[ http://nbn-resolving.de/urn/resolver.pl?urn=nbn%3Ade%3Agbv%3A3-000004374 ]


Gatersleben, 2002


Gutachter: 1. Prof. Dr. Werner Roos

2. PD Dr. Udo Conrad

3. Prof. Dr. Thomas Schmülling


Datum der öffentlichen Verteidigung: 28.11.2002
Halle (Saale)


























This study was carried out in the Institut für Pflanzengenetik und
Kulturpflanzenforschung , Gatersleben, Germany. The investigation was supported by
Deutsche Forschungsgemeinschaft, Bonn, Germany.









Our freedom extends only as far as our consciousness
reaches.

Carl Gustav Jung















List of abbreviations


ALP .......................... alkaline phosphatase
ABA ......................... abscisic acid
r
amp .......................... ampicilin resistance
anti-JA scFv ............. anti-jasmonic acid single-chain Fv antibodies
anti-OPDA scFv....... anti-12-oxo-phytodienoic acid single-chain Fv antibodies
AOC ......................... allene oxide cyclase
AOS.......................... allene oxide synthase
BSA bovine serum albumin
c-myc........................ c-myc tag sequence
CaMV35S................. Cauliflower mosaic virus 35S promoter
CDR ......................... complementary determining region
diHZR....................... dihydro-zeatin riboside
E.coli ........................ Escherichia coli
ELISA ...................... enzyme-linked immunosorbent assay
ER............................. endoplasmic reticulum
EREBP ..................... ethylene-responsive element binding protein
FITC ......................... fluorescein isothiocyanate
GC ............................ gas chromatography
IAA........................... indole-3-acetic acid
JA ............................. (3R,7R)-jasmonic acid
JAME ....................... (3R,7R)-jasmonic acid methyl ester
JAII........................... transgenic plants with anti-JA scFv targeted into the ER
JAVII........................JA scFv targeted into the cytosol
KDEL ....................... retention sequence
LeB4SP .................... legumin B4 signal sequence
LOX ......................... lipoxygenase
MAPK ...................... mitogen-activated protein kinase
MS............................ mass spectrometry
OCM......................... transgenic plants with anti-OPDA scFv targeted into the outer chloroplast membrane
OCMTP.................... outer chloroplast membrane transit sequence
OPDA....................... (9S,13S)-12-oxo-10,15(Z)-phytodienoic acid
OPR.......................... OPDA-reductase
ori ............................. origin of replication
PCR .......................... polymerase chain reaction
Pin 2 ......................... proteinase inhibitor 2 protein
poly A....................... polyadenylation signal
PR............................. pathogenesis-related
PUFA ....................... polyunsaturated fatty acid
ROS.......................... reactive oxygen species
rpm ........................... revolutions per minute
SA............................. salicylic acid
SAR.......................... systemic acquired resistance
scFv single-chain variable fragment
ST3 ........................... transgenic plants with anti-OPDA scFv targeted in the
stroma of chloroplasts
ST3TP ...................... chloroplastic stroma transit sequence
TSP........................... total soluble protein
WT wild type

















Contents


Introduction...................................................................................................... 1
1. Plant defence mechanisms .......................................................................... 1
1.1. Systemic acquired resistance ....................................................................... 3
1.2. Wound response pathway ............................................................................ 4
1.2.1. Early signalling events .............................................................................. 4
1.2.2. Biology of jasmonic acid 5
1.2.3. Jasmonic acid biosynthetic pathway ......................................................... 7
1.2.4. Signalling molecules in wound response pathway ................................... 11
1.2.5. Wound signal transmission 12
1.2.6. Cross-talk between defence signalling pathways...................................... 13
1.2.7. Schematic model of the wound response pathway 14

2. Recombinant antibodies in prokaryotic and eukaryotic cells ......16
2.1. Recombinant antibodies in the prokaryotic cell........................................... 16
2.1.1. Structure and function of antibody molecules .......................................... 16
2.1.2. Recombinant antibody fragments ............................................................. 16
2.1.3. Antibody fragment libraries ...................................................................... 19
2.1.4. Improvements and limitations of antibody-fragments production
in Escherichia coli. ................................................................................... 21
2.2. Recombinant antibodies in the eukaryotic cell ............................................ 22
2.2.1. Antibodies in plants .................................................................................. 22
2.2.2. Immunomodulation 23

Results .................................................................................................................. 26
3. Introduction of scFv antibody fragments into the plant genome. 26
3.1. Organ-specific and cell-compartment-specific accumulation of
recombinant antibodies in plants................................................................... 26
3.2. Recombinant antibodies in the apoplast and in the endoplasmic
reticulum of plant cells 26
3.2.1. Cloning of anti-jasmonate scFv genes into the vector pRTRA 7/3
for retention in the endoplasmic reticulum of plant cells........................... 27
3.3. The accumulation of functional antibodies in the cytosol of
tobacco cells.................................................................................................. 30
3.3.1. Cloning of anti-jasmonate scFv ge
for retention in the cytosol of plant cells.................................................... 30
3.4. The accumulation of scFv antibody fragments in the stroma and
on the outer envelope membrane of tobacco chloroplasts ............................ 32
3.4.1. Cloning of anti-12-oxo-phytodienoid acid scFv genes into
the pRT103 vector for retention in the stroma and embrane of chloroplasts....................................... 32
3.5. Agrobacterium tumefaciens-mediated gene transfer.................................... 36
3.5.1. Cloning of the expression cassettes into binary vector pBIN19 ............... 36
4. Selection and characterization of transgenic plants ......................... 38
4.1. Selection of transgenic plants according to scFv expression level .............. 38
4.2. Immunolocalization of anti-OPDA-F2 scFv in the chloroplastic
subcompartments of tobacco cells ................................................................ 40
4.3. Developmental changes caused by the expression of anti-jasmonate
scFv antibodies.............................................................................................. 41
4.4. Analysis of F1 generation of transgenic tobacco plants............................... 44

5. Analysis of wound stress response in transgenic plants
with anti-jasmonate scFv antibodies ........................................................ 47
5.1. Macroarray analysis of gene expression pattern in response
to mechanical wounding ............................................................................... 47
5.1.1. Macroarray analysis of „in situ“ wounded plants ..................................... 51
5.1.2. Macroarray analysis of detached wounded tobacco leaves ...................... 52
5.1.3. Northern blot ana